Comparative study between botulinum toxin injection and partial division of puborectalis for treating anismus
- PMID: 19039596
- DOI: 10.1007/s00384-008-0609-7
Comparative study between botulinum toxin injection and partial division of puborectalis for treating anismus
Abstract
Objectives: The objective of this study was to compare the results of partial division of puborectalis (PDPR) versus local botulinum toxin type A (BTX-A) injection in treating patients with anismus.
Patients and methods: This prospective randomized study included 30 male patients suffering from anismus. Diagnosis was made by clinical examination, barium enema, colonoscopy, colonic transit time, anorectal manometry, balloon expulsion test, defecography, and electromyography. Patients were randomized into: group I which included 15 patients who were injected with BTX-A and group II which included 15 patients who underwent bilateral PDPR. Follow-up was conducted for about 1 year. Improvement was considered when patients returned to their normal habits.
Results: BTX-A injection achieved initial success in 13 patients (86.7%). However, long-term success persisted only in six patients (40%). This was in contrast to PDPR which achieved initial success in all patients (100%) with a long-term success in ten patients (66.6%). Recurrence was observed in seven patients (53.8%) and five patients (33.4%) following BTX-A injection and PDPR, respectively. Minor degrees of incontinence were confronted in two patients (13.3%) following PDPR.
Conclusion: BTX-A injection seems to be successful for temporary treatment of anismus.
Similar articles
-
Comparative study between surgical and non-surgical treatment of anismus in patients with symptoms of obstructed defecation: a prospective randomized study.J Gastrointest Surg. 2010 Aug;14(8):1235-43. doi: 10.1007/s11605-010-1229-4. Epub 2010 May 25. J Gastrointest Surg. 2010. PMID: 20499203 Clinical Trial.
-
Comparative study between biofeedback retraining and botulinum neurotoxin in the treatment of anismus patients.Int J Colorectal Dis. 2009 Jan;24(1):115-20. doi: 10.1007/s00384-008-0567-0. Epub 2008 Aug 22. Int J Colorectal Dis. 2009. PMID: 18719924 Clinical Trial.
-
Treatment of anismus in intractable constipation with botulinum A toxin.Lancet. 1988 Sep 24;2(8613):714-7. doi: 10.1016/s0140-6736(88)90188-2. Lancet. 1988. PMID: 2901570
-
The use of botulinum toxin for treatment of lower urinary tract symptoms.Minerva Urol Nefrol. 2008 Jun;60(2):93-103. Minerva Urol Nefrol. 2008. PMID: 18500224 Review.
-
Botulinum toxin: a review of applications for the head and neck.Gen Dent. 2019 Mar-Apr;67(2):55-58. Gen Dent. 2019. PMID: 30875307 Review.
Cited by
-
The Role of Botox in Colorectal Disorders.Curr Treat Options Gastroenterol. 2018 Dec;16(4):541-547. doi: 10.1007/s11938-018-0205-z. Curr Treat Options Gastroenterol. 2018. PMID: 30397849 Review.
-
Impact of Botulinum Neurotoxin Pyloric Injection During Laparoscopic Sleeve Gastrectomy on Postoperative Gastric Leak: a Clinical Randomized Study.Obes Surg. 2016 Mar;26(3):494-504. doi: 10.1007/s11695-015-1794-4. Obes Surg. 2016. PMID: 26198617 Clinical Trial.
-
Botulinum toxin type-A injection to treat patients with intractable anismus unresponsive to simple biofeedback training.World J Gastroenterol. 2014 Sep 21;20(35):12602-7. doi: 10.3748/wjg.v20.i35.12602. World J Gastroenterol. 2014. PMID: 25253964 Free PMC article.
-
Functional Disorders of Constipation: Paradoxical Puborectalis Contraction and Increased Perineal Descent.Clin Colon Rectal Surg. 2017 Feb;30(1):22-29. doi: 10.1055/s-0036-1593430. Clin Colon Rectal Surg. 2017. PMID: 28144209 Free PMC article. Review.
-
Efficacy of biofeedback plus transanal stimulation in the management of pelvic floor dyssynergia: a randomized trial.Tech Coloproctol. 2015 Jun;19(6):333-8. doi: 10.1007/s10151-015-1292-7. Epub 2015 Mar 6. Tech Coloproctol. 2015. PMID: 25744688 Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical